Skip to main content

Glutathione (GSH) vs SS-31

Both Glutathione (GSH) and SS-31 are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

Glutathione (GSH)

Evidence B

Reduced L-Glutathione

Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.

View full Glutathione (GSH) profile →

SS-31

Evidence B+

Elamipretide (SS-31)

A cell-permeable tetrapeptide that targets cardiolipin in the inner mitochondrial membrane. Investigated for primary mitochondrial myopathy, heart failure, and dry age-related macular degeneration.

View full SS-31 profile →

Side-by-Side

AttributeGlutathione (GSH)SS-31
Evidence GradeBB+
FDA StatusNot FDA-approved as therapeutic — sold as supplement; intravenous use compoundedNot FDA-approved — Phase 3 trials for primary mitochondrial myopathy
Typical Dose200–600 mg sublingual / 600–2400 mg IV (compounded)Trial range: 40 mg subcutaneous daily
Clinics Indexed31229
Categoriesantioxidant, longevitymitochondrial, longevity

Key reported benefits — Glutathione (GSH)

  • Master antioxidant
  • Liver detoxification support
  • Oxidative stress reduction

Key reported benefits — SS-31

  • Mitochondrial cardiolipin support
  • ATP production
  • Reduced oxidative damage

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons